… pure nicotine on various cells involved in COVID-19 … nicotine in damaged organs
corresponding to COVID-19 pathogenesis (12 related diseases). Considering that the effects of …

… However, clear evidence supporting the value of VNS in treating COVID-19 is lacking. …
suggests that nicotinic receptors (nAChRs) have a pivotal role in the pathogenesis of COVID-19. …

… Coronavirus disease 2019 (COVID-19) is a current pandemic disease caused by a novel
severe acute respiratory syndrome coronavirus virus … , native alpha-7 nicotinic subunit, and its …

… COVID-19 infection [10]. Inflammatory status can be controlled by activating the cholinergic
system … varenicline regularly or used nicotine patch developed COVID-19 disease. Moreover, …

… supports the nicotinic cholinergic system dysregulation hypothesis in COVID-19 pathophysiology
leading … However, the hypothesis of the nicotinic cholinergic dysregulation in COVID-19 …

… cholinergic system (… cholinergic anti-inflammatory pathway [182], efferent nerve traffic from
the dorsal motor nucleus of the vagus nerve increases delivery of acetylcholine to α7 nicotinic …

… specific mixture of nicotinic cholinergic agonists could reduce COVID-19 disease severity, …
in the anti-inflammatory response of the cholinergic system [19]. This interaction between the …

… It has also been suggested that nicotine glue can reduce the contamination of COVID-19
and reduce the number of people seeking medical attention (39). Of course, these findings do …

… a dysfunction of the striatal cholinergic system. A down … nicotine delivery to prevent and
treat COVID-19, we set up three trials–one for prevention, and others for patients with COVID-19 …

… among COVID19, nicotine, and the complement system/factor H. However, further studies
are needed to define the consequences of nicotine exposure during COVID19 infection for this …